NO924679L - Kontrastmidler for ultralydbilleder - Google Patents

Kontrastmidler for ultralydbilleder

Info

Publication number
NO924679L
NO924679L NO92924679A NO924679A NO924679L NO 924679 L NO924679 L NO 924679L NO 92924679 A NO92924679 A NO 92924679A NO 924679 A NO924679 A NO 924679A NO 924679 L NO924679 L NO 924679L
Authority
NO
Norway
Prior art keywords
contractors
ultra sound
sound images
contrast agents
dispersed microbubbles
Prior art date
Application number
NO92924679A
Other languages
English (en)
Norwegian (no)
Other versions
NO924679D0 (no
Inventor
Joseph Yudelson
Susan E Power
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of NO924679D0 publication Critical patent/NO924679D0/no
Publication of NO924679L publication Critical patent/NO924679L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/225—Microparticles, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
NO92924679A 1991-12-04 1992-12-04 Kontrastmidler for ultralydbilleder NO924679L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/803,293 US5196183A (en) 1991-12-04 1991-12-04 Contrast agents for ultrasound imaging

Publications (2)

Publication Number Publication Date
NO924679D0 NO924679D0 (no) 1992-12-04
NO924679L true NO924679L (no) 1993-06-07

Family

ID=25186146

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924679A NO924679L (no) 1991-12-04 1992-12-04 Kontrastmidler for ultralydbilleder

Country Status (22)

Country Link
US (1) US5196183A (ko)
EP (1) EP0547654A1 (ko)
JP (1) JP2769077B2 (ko)
KR (1) KR930012039A (ko)
CN (1) CN1073880A (ko)
AU (1) AU2857292A (ko)
BR (1) BR9204841A (ko)
CA (1) CA2084432A1 (ko)
CZ (1) CZ352992A3 (ko)
FI (1) FI925526A (ko)
HU (2) HU9203845D0 (ko)
IL (1) IL103951A0 (ko)
IS (1) IS3955A (ko)
MX (1) MX9206980A (ko)
MY (1) MY134715A (ko)
NO (1) NO924679L (ko)
PL (1) PL296827A1 (ko)
SK (1) SK352992A3 (ko)
TN (1) TNSN92111A1 (ko)
TW (1) TW221791B (ko)
UY (1) UY23515A1 (ko)
YU (1) YU103792A (ko)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146657A (en) 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US5776429A (en) 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US20020150539A1 (en) * 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5705187A (en) * 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials
US5922304A (en) 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US6001335A (en) 1989-12-22 1999-12-14 Imarx Pharmaceutical Corp. Contrasting agents for ultrasonic imaging and methods for preparing the same
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5305757A (en) 1989-12-22 1994-04-26 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US5352435A (en) * 1989-12-22 1994-10-04 Unger Evan C Ionophore containing liposomes for ultrasound imaging
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5656211A (en) 1989-12-22 1997-08-12 Imarx Pharmaceutical Corp. Apparatus and method for making gas-filled vesicles of optimal size
US5773024A (en) * 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5874062A (en) 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
US5993805A (en) 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
EP0669823A4 (en) * 1992-10-06 1996-03-13 Molecular Biosystems Inc METHOD FOR ULTRASONIC IMAGING OF BODY CAVITIES.
GB9221329D0 (en) 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Colloids with phase difference as contrast ultrasound agents
US5362478A (en) * 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
CA2164813C (en) * 1993-07-30 2009-11-24 Ernest G. Schutt Stabilized microbubble compositions for ultrasound
US5798091A (en) 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
US7083572B2 (en) * 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US5736121A (en) * 1994-05-23 1998-04-07 Imarx Pharmaceutical Corp. Stabilized homogenous suspensions as computed tomography contrast agents
US5509896A (en) * 1994-09-09 1996-04-23 Coraje, Inc. Enhancement of thrombolysis with external ultrasound
US5540909A (en) * 1994-09-28 1996-07-30 Alliance Pharmaceutical Corp. Harmonic ultrasound imaging with microbubbles
GB9423419D0 (en) * 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US6743779B1 (en) 1994-11-29 2004-06-01 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US5830430A (en) 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
US6033645A (en) 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US5804162A (en) 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US6139819A (en) 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US6521211B1 (en) * 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
CA2252617A1 (en) 1996-05-01 1997-11-06 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
US6017310A (en) * 1996-09-07 2000-01-25 Andaris Limited Use of hollow microcapsules
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
DK1323434T3 (da) 1996-09-11 2007-11-12 Bristol Myers Squibb Medical I Fremgangsmåde til diagnostisk billeddannelse af nyreregioner under anvendelse af et kontrastmiddel og en vasodilator
US8137684B2 (en) 1996-10-01 2012-03-20 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US6068600A (en) * 1996-12-06 2000-05-30 Quadrant Healthcare (Uk) Limited Use of hollow microcapsules
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6143276A (en) 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6537246B1 (en) * 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US20050019266A1 (en) * 1997-05-06 2005-01-27 Unger Evan C. Novel targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US6123923A (en) 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US6638230B2 (en) * 2001-07-31 2003-10-28 Koninklijke Philips Electronics N.V. Apparatus and method of frequency compounding to perform contrast imaging
US7737097B2 (en) * 2003-06-27 2010-06-15 Lam Research Corporation Method for removing contamination from a substrate and for making a cleaning solution
US8364256B2 (en) * 2004-11-15 2013-01-29 Coraje, Inc. Method and apparatus of removal of intravascular blockages
CN100574811C (zh) * 2005-01-10 2009-12-30 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用微粒类助剂及其应用
CN100574809C (zh) * 2005-01-10 2009-12-30 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用氟碳乳剂类助剂及其应用
US7715517B2 (en) * 2006-09-13 2010-05-11 Holtec International, Inc. Apparatus and method for supporting fuel assemblies in an underwater environment having lateral access loading
EP2668961A4 (en) 2010-11-19 2016-07-06 Univ Sapporo Medical PHARMACEUTICAL COMBINATION PREPARATION
US9976142B2 (en) 2014-04-02 2018-05-22 Nitto Denko Corporation Targeting molecule and a use thereof
GB201415681D0 (en) * 2014-09-04 2014-10-22 Cambridge Entpr Ltd And President And Fellows Of Harvard College Protien Capsules
WO2022014762A1 (ko) * 2020-07-16 2022-01-20 ㈜에어레인 연소배가스의 이산화탄소 포집 및 질소 농축을 동시에 수행하는 다단 막분리공정

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4718433A (en) * 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
US4572203A (en) * 1983-01-27 1986-02-25 Feinstein Steven B Contact agents for ultrasonic imaging
DE3834705A1 (de) * 1988-10-07 1990-04-12 Schering Ag Ultraschallkontrastmittel aus gasblaeschen und fettsaeure enthaltenden mikropartikeln
PT81498B (pt) * 1984-11-23 1987-12-30 Schering Ag Processo para a preparacao de composicoes para diagnostico contendo particulas magneticas
DE3529195A1 (de) * 1985-08-14 1987-02-26 Max Planck Gesellschaft Kontrastmittel fuer ultraschalluntersuchungen und verfahren zu seiner herstellung
US4844882A (en) * 1987-12-29 1989-07-04 Molecular Biosystems, Inc. Concentrated stabilized microbubble-type ultrasonic imaging agent
US4957656A (en) * 1988-09-14 1990-09-18 Molecular Biosystems, Inc. Continuous sonication method for preparing protein encapsulated microbubbles

Also Published As

Publication number Publication date
JPH05194278A (ja) 1993-08-03
BR9204841A (pt) 1993-06-08
US5196183A (en) 1993-03-23
EP0547654A1 (en) 1993-06-23
HUT67164A (en) 1995-02-28
IL103951A0 (en) 1993-05-13
SK352992A3 (en) 1994-12-07
FI925526A (fi) 1993-06-05
PL296827A1 (en) 1993-12-27
TW221791B (ko) 1994-03-21
FI925526A0 (fi) 1992-12-04
CN1073880A (zh) 1993-07-07
YU103792A (sh) 1995-12-04
AU2857292A (en) 1993-06-17
MY134715A (en) 2007-12-31
NO924679D0 (no) 1992-12-04
IS3955A (is) 1993-06-05
UY23515A1 (es) 1993-05-21
KR930012039A (ko) 1993-07-20
HU9203845D0 (en) 1993-03-29
CZ352992A3 (en) 1993-09-15
JP2769077B2 (ja) 1998-06-25
CA2084432A1 (en) 1993-06-05
MX9206980A (es) 1993-06-01
TNSN92111A1 (fr) 1993-06-08

Similar Documents

Publication Publication Date Title
NO924679L (no) Kontrastmidler for ultralydbilleder
NO942560L (no) Mikropartikulære kontrastmidler med amfifile organiske syrer
CA2268324A1 (en) Administrable compositions and methods for magnetic resonance imaging
BR9906530A (pt) Compósito odontológico
CA2181340A1 (en) Method of storage of ultrasonic gas suspensions
IT1297396B1 (it) Metodo e dispositivo per la ricostruzione di immagini tridimensionali di vasi sanguigni, in particolare di arterie coronarie, o di altre
Buchanan et al. Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature
HUP0102878A2 (hu) Továbbfejlesztett kontrasztanyagok
DE69002767D1 (de) Fluor- und phosphorhaltige amphiphilische molekuele mit oberflaechenaktiven eigenschaften.
NO854765L (no) Anvendelse av ferromagnetiske partikler i kontrastmidler for nmr-avbildning og kontrastmidler.
Thakkar et al. An in vitro comparison of casein phosphopeptide-amorphous calcium phosphate paste, casein phosphopeptide-amorphous calcium phosphate paste with fluoride and casein phosphopeptide-amorphous calcium phosphate varnish on the inhibition of demineralization and promotion of remineralization of enamel
NO924481L (no) Innkapslede partikler egnet som kontrastmidler i ultralyd- og roentgenavbildningssammensetninger og -fremgangsmaater
JP2004513093A5 (ko)
NO305012B1 (no) Dispersjoner av magneto-ioniske partikler og anvendelse derav
Rykke et al. Zeta potentials of human salivary micelle-like particles
Osborne et al. Mechanical properties and clinical performance of a gallium restorative material
Lotke et al. Studies on the functional and biochemical changes during kidney preservation
Rykke et al. Transmission electron microscopy of human saliva
RU92004556A (ru) Контрастное вещество для ультразвуковой диагностики и способ его получения
Tochio et al. Makeup inhibits reduction of reactive oxygen scavenging enzyme activity induced by mental stress
Reeh Salivary defense against friction and wear of dental enamel
Chakrabarti et al. The effect of plasma fibrinogen levels on measures of fibrinolytic activity
MAREN BLOOD FLOW TO ADIPOSE TISSUES IN THE MALE SPRAGUE-DAWLEY RAT.
刘超 et al. Effects of sex hormones on apoptosis in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
Chermant Image Analysis and Metallurgy